Press release content from Newswire. The AP news staff was not involved in its creation.
Patients Choice Laboratories Launches PCR Saliva COVID-19 Test
February 16, 2021 GMT
Patients Choice Laboratories Launches PCR Saliva COVID-19 Test
INDIANAPOLIS - February 16, 2021 - ( Newswire.com )
Patients Choice Laboratories (PCL), a leading life sciences company, is proud to offer its COVID+ Saliva Test, a COVID-19 saliva test by PCR. The COVID+ Saliva Test is non-invasive, safe and reliable. The COVID+ Saliva Test with same day results is appealing to patients as it is less invasive, painless and as accurate as nasopharyngeal or nasal swab COVID-19 testing. Due to its simplicity, clinicians are at less risk because patients can collect their own specimens into a vial with no required contact with a healthcare worker.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Ontario International Airport began 2021 with double-digit gain in cargo volume while pandemic continued to depress passenger numbers
February 16, 2021 GMT
ONTARIO, Calif., Feb. 16, 2021 /PRNewswire/ Ontario International Airport (ONT) began 2021 just as it closed out 2020, with a double-digit increase in commercial freight volume while the COVID-19 pandemic continued to depress passenger numbers.
January freight volume totaled more than 70,500 tons, a 15.6% increase compared to the same month last year and extending a trend of robust cargo shipments as Southern Californians continued to rely heavily on e-commerce to keep their households and businesses supplied. At the same time, shipments of mail more than doubled year-over-year to 3,225 tons.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Concierge Technologies Reports Financial Results for Second Fiscal Quarter
February 16, 2021 GMT
- Revenues Nearly Double, Stockholders’ Equity Continues to Rise Over Prior Year -SAN CLEMENTE, CA / ACCESSWIRE / February 16, 2021 / Concierge Technologies, Inc. (OTCQB:CNCG), a diversified global holding firm, today announced financial results for the second fiscal quarter ended December 31, 2020, with strong performances in revenues, net income and stockholders’ equity.The Company reported that for the three months ended December 31, 2020, revenues continued their increase to $10.0 million from $5.8 million for the comparable prior year period. For the six months ended December 31, 2020, revenues advanced to $20.7 million from $11.8 million for the same period last year. Net income for the most recent three-month period rose to $1.4 million, equal to $0.04 per share, from a net loss of $75
Press release content from Business Wire. The AP news staff was not involved in its creation.
Eyevensys Named to French Tech 120 Program
February 15, 2021 GMT
PARIS & CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 15, 2021
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been accepted into the French Tech 120 program for 2021.
This government-backed program, run by La French Tech, offers support for 120 French startups considered late-stage and in a hypergrowth phase. Participating companies benefit from a variety of initiatives designed to support the needs of companies in this stage, such as unlimited access to government, public and ministry services, as well as tailored services from partner agencies. Participants will also benefit from collaboration with the French Tech 120 community, and a needs analysis that will help shape future regulations.